Key Takeaway
After 4 months on Wegovy, most patients lose 14 to 20 pounds as they reach the 1.7 mg dose. Here is a detailed timeline with clinical references and practical advice.
Four months on Wegovy brings you to the penultimate dose step, and the results reflect that progress. Most patients looking at Wegovy results after 4 months have lost 14 to 20 pounds, which amounts to roughly 6% to 8% of their starting body weight . You're now at the 1.7 mg dose, one step below the 2.4 mg maintenance level, and the medication is near full strength.
The 1.7 mg Dose: Penultimate Power
Month four on Wegovy means you're at 1.7 mg weekly . Here is where this sits in the full schedule:
| Month | Dose | Status |
|---|---|---|
| 1 | 0.25 mg | Complete |
| 2 | 0.5 mg | Complete |
| 3 | 1.0 mg | Complete |
| 4 | 1.7 mg | Current |
| 5+ | 2.4 mg | Next month |
The 1.7 mg dose is where patients frequently report the strongest appetite suppression they have experienced so far. The jump from 1.0 mg to 1.7 mg (a 70% increase) produces a noticeable effect for most patients.
Week-by-Week Breakdown of Month Four
Week 13: Transitioning to 1.7 mg
- Appetite suppression increases substantially
- GI side effects may briefly recur (nausea lasting 1 to 2 days is common)
- Patients often describe feeling satisfied after just a few bites
- Weekly weight loss of 1.5 to 2 pounds
Week 14: Strong and Steady
- Your body adjusts to the new dose
- Food noise is at its quietest yet
- Physical stamina improves as weight decreases
- Blood pressure may have dropped enough to discuss reducing BP medications
Weeks 15 to 16: Approaching the Finish Line
- Total weight loss reaches 14 to 20 pounds
- Waist circumference down 2.5 to 4 inches from start
- Many patients need new clothes at this point
- Provider prepares you for the final step to 2.4 mg
Four-Month Results Data
| Marker | Typical Result at 4 Months |
|---|---|
| Total weight loss | 14 to 20 pounds |
| Body weight percentage | 6% to 8% |
| Waist circumference | 2.5 to 4 inches lost |
| Fasting glucose | 15 to 30 mg/dL decrease |
| LDL cholesterol | 5% to 15% decrease |
In the STEP 1 trial[1], participants on semaglutide 2.4 mg lost approximately 9% of body weight by week 16 . Patients at the 1.7 mg dose are close to this benchmark, with additional loss expected upon reaching the maintenance dose next month. For a complete cost breakdown, see our semaglutide pricing comparison.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Side Effects at 1.7 mg
The dose increase from 1.0 to 1.7 mg is the largest percentage jump in the Wegovy titration. Side effects to watch for include :
- Nausea: May recur briefly. Usually milder and shorter than earlier episodes.
- Reduced appetite to the point of food aversion: Some patients develop temporary aversions to specific foods, particularly meats and rich dishes.
- Constipation: Remains the most persistent GI issue. A consistent daily routine of fiber, magnesium, and water is important.
- Heartburn: May develop or worsen. Consider improving the head of your bed and avoiding eating within 3 hours of bedtime.
- Dizziness: Possible if eating too little. Ensure adequate calorie and fluid intake.
If side effects are unmanageable, your provider may recommend staying at 1.7 mg longer before advancing, or even stepping back to 1.0 mg temporarily .
Tips for the Final Stretch Before Maintenance
- Maintain minimum caloric intake. Don't drop below 1200 calories daily for women or 1500 for men, even if you aren't hungry.
- Eat nutrient-dense foods. Every meal should include lean protein, vegetables, and healthy fats.
- Increase exercise if able. Aim for 150 to 200 minutes of moderate activity per week.
- Plan for 2.4 mg. Talk to your provider about what to expect when you reach the maintenance dose next month.
- Celebrate your progress. Losing 15+ pounds in four months is a significant achievement that improves your health in countless ways.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
What happens when I reach the 2.4 mg maintenance dose?
At 2.4 mg, you're at the full therapeutic dose. Weight loss typically continues for several more months before stabilizing. Many patients reach peak weight loss between months 8 and 12 on the maintenance dose Wegovy results after 6 months.
Can I stay at 1.7 mg if I am happy with my results?
Some patients choose to remain at 1.7 mg, especially if they're tolerating it well and seeing adequate progress. Clinical data suggests that 2.4 mg produces more weight loss, but the difference may not be worth it for everyone .
How do I manage social events and eating out?
Order smaller portions or share entrees. Focus on protein and vegetables. Don't feel pressured to clean your plate. Most patients find that reduced appetite makes restaurant dining easier because they're satisfied with less.
Is the weight loss sustainable if I stop Wegovy?
Research shows that most patients regain weight after discontinuing GLP-1 medications. Maintaining an active lifestyle and healthy eating habits can slow regain, but many patients benefit from continued treatment .
When should I get new blood work?
Four months is an excellent time for a thorough metabolic panel, lipid profile, and A1C test. These results help your provider improve your treatment and document your health improvements FormBlends telehealth consultation.